NCT00072111View on ClinicalTrials.gov

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2003

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

anakinra

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00072111 - Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | Biotech Hunter | Biotech Hunter